Aleksandr Ianevski
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 5
-
- Computational Drug Discovery Methods 15
- Molecular Biology top 5%
- Single-cell and spatial transcriptomics 6
- Oncology top 5%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 5
-
- Influenza Virus Research Studies 6
-
- Acute Myeloid Leukemia Research 6
-
- interferon and immune responses 5
In The Last Decade
Aleksandr Ianevski
51 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Infectious Diseases 507
- Computational Theory and Mathematics 373
- Molecular Biology 1.5k
- Oncology 557
- Cancer Research 300
Countries citing papers authored by Aleksandr Ianevski
This map shows the geographic impact of Aleksandr Ianevski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandr Ianevski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandr Ianevski more than expected).
Fields of papers citing papers by Aleksandr Ianevski
This network shows the impact of papers produced by Aleksandr Ianevski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandr Ianevski. The network helps show where Aleksandr Ianevski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aleksandr Ianevski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 35 | |
| 11 | 2022 | 34 | |
| 12 | 2022 | 23 | |
| 13 | Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic databreakdown → | 2022 | 298 |
| 14 | 2022 | 20 | |
| 15 | 2021 | 30 | |
| 16 | 2021 | 27 | |
| 17 | 2021 | 36 | |
| 18 | 2021 | 42 | |
| 19 | 2019 | 157 | |
| 20 | 2019 | 106 |
About Aleksandr Ianevski
Aleksandr Ianevski is a scholar working on Computational Theory and Mathematics, Infectious Diseases and Immunology, having authored 54 papers that have together received 2.8k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Influenza Virus Research Studies (6 papers), Single-cell and spatial transcriptomics (6 papers), Acute Myeloid Leukemia Research (6 papers), interferon and immune responses (5 papers), COVID-19 Clinical Research Studies (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Infectious Diseases (507 citations), Computational Theory and Mathematics (373 citations) and Molecular Biology (1.5k citations). Aleksandr Ianevski has collaborated with scholars based in Finland, Norway and Estonia. Frequent co-authors include Tero Aittokallio, Anil K. Giri, Liye He, Jing Tang, Denis E. Kainov, Magnar Bjørås, Tanel Tenson, Krister Wennerberg, Valentyn Oksenych and Petter I. Andersen. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.